Approaches to use the WHO respiratory syncytial virus surveillance platform to estimate disease burden

Influenza Other Respir Viruses. 2020 Nov;14(6):615-621. doi: 10.1111/irv.12667. Epub 2019 Oct 8.

Abstract

The World Health Organization (WHO) recently completed the first phase of a RSV surveillance pilot study in fourteen countries (two to three in each WHO region) building on the Global Influenza Surveillance and Response System (GISRS). This active surveillance strategy had several objectives including understanding RSV-related health burden in a variety of settings. A range of approaches can be used to estimate disease burden; most approaches could not be applied by participating countries in the WHO surveillance pilot. This article provides the recommendations made by WHO for strengthening and expanding the scope of the RSV surveillance in the next phase to enable burden estimation.

Keywords: burden; respiratory syncytial virus; surveillance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost of Illness*
  • Data Collection
  • Humans
  • Pilot Projects
  • Population Surveillance*
  • Respiratory Syncytial Virus Infections / economics*
  • Respiratory Syncytial Virus Infections / epidemiology
  • Respiratory Syncytial Virus, Human
  • World Health Organization